Eczema Patients Have Lost Faith In Treatment: Survey

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2022-09-13 HKT 20:53

Share this story

facebook

  • Eczema patients have lost faith in treatment: survey

A international survey has found that only 37 percent of eczema patients in the city are working on treatment plans with doctors, while two-thirds have lost hope.

GlobalSkin, an international alliance of dermatology patient organisations, initiated the study covering 330 eczema patients in the SAR, South Korea and Australia in August, with one-third of the respondents in Hong Kong.

Dermatologist Dr Johnny Chan said on Tuesday that the proportion of patients in the city seeking medical advice is “very low”.

He said more than 90 percent of them are being treated by public practitioners, but strained medical resources due to the Covid-19 pandemic have delayed their treatment.

“The queue time of every [eczema] treatment will be two to three years at the moment," he said, adding that does not taken into account the impact Covid has had on waiting times even longer.

“While they are waiting, they think the treatments will not be helping them, and may lose the faith in treatment. They think it’s just incurable, they don’t want to have any treatment anymore,” Chan said.

“Public doctors have a limited time to see a lot of patients every day."

But for moderate to severe cases, he said, "they need some more time for explanations about the disease nature: to have a more tailor-made treatment plan for the patients, and to explain any possible side effects and the way to avoid these side effects.”

Chan added that less than 10 percent of eczema sufferers had sought treatment from the private sector. He said high costs was "very much an issue" here, with 72 percent of patients saying the heavy financial burden had deterred them from visiting doctors.

Dr Marco Ho, who chairs the Hong Kong Allergy Association, said when treatment is delayed, a patients’ immune system further deregulates and their conditions worsen, hence their expectations in consultations can be over-optimistic.

“Sometimes you don’t have the best-matched medication treatment as well as therapies. They have a whole lot of ideas and their own personal belief, so end up when we say ‘control’, they say ‘cure’; when we say ‘short-term gain’, they want a ‘long-term' remission,” he said.

“At times we even think the patient needs hospitalisation [but] they can't afford to stop their work or school.”

To clear up such misinterpretations and handle mental problems when patients are suffering from skin conditions, the allergy association and a concern group under the Hong Kong Health Care Alliance launched a free online counseling service on Tuesday that will run for three months.

RECENT NEWS

EX.IO Partners With Franklin Templeton To Expand Tokenised Assets In Hong Kong

EX.IO, a licensed virtual asset trading platform in Hong Kong, has formed a strategic partnership with global investmen... Read more

HKMC Prices HK$12 Billion Digital Bond Issuance, Largest Globally

The Hong Kong Mortgage Corporation Limited (HKMC) has priced its inaugural digital bond issuance, raising approximately... Read more

MUFG, SMFG And Mizuho Plan Joint Yen Stablecoin By March 2027

Three of Japan’s largest financial groups, MUFG, SMBC, and Mizuho, plan to jointly issue a stablecoin by March 2027, ... Read more

TransUnion Launches Free Credit Reports For Lost HKID Holders In Hong Kong

TransUnion is offering a one-time free credit report to eligible individuals in Hong Kong who have lost their Hong Kong... Read more

Why HSMs Are Becoming Essential For Digital Asset Key Security

Conversations revolving around digital asset finance often return to the blockchain, but Shaun Chen’s concern sits cl... Read more

Webinar: The Deepfake Threat And What APAC Financial Institutions Are Doing About It

Generative AI is making fraud more convincing and easier to scale. Reports of Gen AI-enabled scams rose 456% between Ma... Read more